These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2417187)

  • 21. [Administration of levamisole to children with kidney disease exacerbation caused by recurrent respiratory infections].
    Prandota J; Kobylińska J; Lipowska K
    Pol Tyg Lek; 1989 Jul 10-17; 44(28-29):673-6. PubMed ID: 2637440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical use of human leukocyte interferon in viral infections.
    Ikić D; Trajer D; Cupak K; Petricević I; Prazić M; Soldo I; Jusic D; Smerdel S; Soos E
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):498-505. PubMed ID: 6170597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of an interferon inducer in viral respiratory disease.
    Hill DA; Baron S; Perkins JC; Worthington M; Van Kirk JE; Mills J; Kapikian AZ; Chanock RM
    JAMA; 1972 Feb; 219(9):1179-84. PubMed ID: 4334380
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon-containing plasma: the preparation for treatment of viral infections.
    Skurkovich SV; Arkhipova NA; Olshanskaya NV; Eremkina EI; Krokhina MA; Klinova EG; Kolpikova LA; Sidorova NS; Kogan EM; Naumovich NS; Bresler SE; Timkovski AL; Salganik RI; Zakabunin AI; Makhonova LA; Majakova SA; Leschynskaya EV
    Biomedicine; 1978 Nov; 29(7):227-8. PubMed ID: 747728
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of leukocyte interferon for the prevention and treatment of several viral infections].
    Ermol'eva ZV; Furer NM
    Klin Med (Mosk); 1970 Apr; 48(4):40-50. PubMed ID: 4316630
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ribavirin treatment of viral infections of the lower respiratory tract].
    Corretger Rauet JM; Tardío Torío E; Sánchez Sánchez E
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():137-8. PubMed ID: 2490606
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interferonogenic properties of prodigiozan and its effectiveness in treating acute respiratory diseases in children].
    Povolotskiĭ IaL; Andrushchuk AA; Korzhenevskiĭ AF; Krivokhatskaia LD
    Antibiotiki; 1980 Jul; 25(7):531-4. PubMed ID: 6157358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of interferon for prevention of acute respiratory viral diseases in children's collectives (literature survey)].
    Turgunbaev OT
    Zdravookhr Kirg; 1975; (5):57-9. PubMed ID: 1945
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of the experimental study of interferon inducers].
    Ershov FI; Bukata LA
    Antibiotiki; 1979 Sep; 24(9):700-15. PubMed ID: 384894
    [No Abstract]   [Full Text] [Related]  

  • 30. A placebo controlled, double-blind evaluation of levamisole in the reduction of the frequency, duration and severity of attacks in children suffering from recurrent upper respiratory tract infections.
    Dils F
    J Int Med Res; 1979; 7(4):302-4. PubMed ID: 385400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correction of immunity dysbalance in children with frequent recurrent respiratory infection].
    Kharitinova LA; Israfilova OE; Romantsov MG
    Antibiot Khimioter; 2013; 58(11-12):19-22. PubMed ID: 24734424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The pathogenetic therapy of acute respiratory diseases by aprotinin inhalations].
    Zhirnov OP; Kirzhner LS; Ovcharenko AV; Malyshev NA
    Ter Arkh; 1995; 67(6):38-42. PubMed ID: 7545316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibacterial and pathogenetic therapy of acute respiratory viral infections, viral pneumonias and viral diarrheas in children].
    Pryknod'ko VS; Odynets' IuV; Bezkorovaĭna OI; Shovkoplias IuA; Iablons'ka NN
    Pediatr Akus Ginekol; 1980; (2):11-4. PubMed ID: 7383715
    [No Abstract]   [Full Text] [Related]  

  • 34. [The role of the antiviral immunity factor in the treatment of young children with acute viral respiratory infections].
    Trajković S; Jovanović J
    Med Pregl; 1987; 40(9-10):431-4. PubMed ID: 2453785
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indices of circulating interferon in different viral diseases].
    Lavrukhina LA; Ershov FI; Krylov VF; Kniazeva LD; Belostotskaia OI
    Vopr Virusol; 1989; 34(2):244-7. PubMed ID: 2474908
    [No Abstract]   [Full Text] [Related]  

  • 36. Levamisole in prevention of recurrent upper-respiratory-tract infections in children.
    Van Eygen M; Znamensky PY; Heck E; Raymaekers I
    Lancet; 1976 Feb; 1(7956):382-5. PubMed ID: 55648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Description of the leukocyte count dynamics in pneumonia and acute respiratory viral infection].
    Ryneĭskaia ES; Tatochenko VT; Sokolova AF; Nartsissov RP
    Pediatriia; 1981 Jan; (1):23-5. PubMed ID: 7208176
    [No Abstract]   [Full Text] [Related]  

  • 38. Levamisole (R 12564) in the prevention of recurrent upper respiratory tract infections in children: a double-blind, placebo-controlled study.
    De Loore F; Heck E; Van Eygen M; Casneuf J
    Curr Med Res Opin; 1979; 6(2):142-7. PubMed ID: 380912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospects for the clinical use of exogenous interferon.
    Cantell K
    Med Biol; 1977 Apr; 55(2):69-73. PubMed ID: 194114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a topical interferon inducer on rhinovirus infections in volunteers.
    Stanley ED; Jackson GG; Dirda VA; Rubenis M
    J Infect Dis; 1976 Jun; 133 Suppl():A121-127. PubMed ID: 180192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.